Candel Therapeutics (CADL) Insider Trading & Ownership $4.46 -0.11 (-2.41%) (As of 12:57 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Candel Therapeutics (NASDAQ:CADL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage41.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$753,016.01 Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CADL Insider Buying and Selling by Quarter Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Candel Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/14/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.02$90,300.00 10/11/2024Estuardo Aguilar-CordovaMajor ShareholderSell15,000$6.05$90,750.00 10/3/2024Estuardo Aguilar-CordovaMajor ShareholderSell1,800$6.85$12,330.00 7/17/2024Charles SchochInsiderSell9,884$6.47$63,949.48 7/17/2024Paul Peter TakCEOSell22,528$6.47$145,756.16 7/17/2024Seshu TyagarajanCTOSell14,851$6.47$96,085.97 7/11/2024Charles SchochInsiderSell8,897$5.97$53,115.09 7/11/2024Paul Peter TakCEOSell20,293$5.97$121,149.21 7/11/2024Seshu TyagarajanCTOSell13,330$5.97$79,580.10 (Data available from 1/1/2013 forward) CADL Insider Trading Activity - Frequently Asked Questions Who is on Candel Therapeutics's Insider Roster? The list of insiders at Candel Therapeutics includes Charles Schoch, Estuardo Aguilar-Cordova, Francesca Barone, Jason Amello, Joseph C Papa, Paul Peter Tak, and Seshu Tyagarajan. Learn more on insiders at CADL. What percentage of Candel Therapeutics stock is owned by insiders? 41.60% of Candel Therapeutics stock is owned by insiders. Learn more on CADL's insider holdings. Which Candel Therapeutics insiders have been buying company stock? The following insiders have purchased CADL shares in the last 24 months: Francesca Barone ($1,993.18), Jason Amello ($5,239.00), Joseph C Papa ($5,123.80), Paul Peter Tak ($5,185.00), and Seshu Tyagarajan ($5,070.00). How much insider buying is happening at Candel Therapeutics? Insiders have purchased a total of 13,402 CADL shares in the last 24 months for a total of $22,610.98 bought. Which Candel Therapeutics insiders have been selling company stock? The following insiders have sold CADL shares in the last 24 months: Charles Schoch ($117,064.57), Estuardo Aguilar-Cordova ($193,380.00), Paul Peter Tak ($266,905.37), and Seshu Tyagarajan ($175,666.07). How much insider selling is happening at Candel Therapeutics? Insiders have sold a total of 121,583 Candel Therapeutics shares in the last 24 months for a total of $753,016.01 sold. Candel Therapeutics Key ExecutivesDr. Paul-Peter Tak FMEDSCI (Age 63)M.D., Ph.D., President, CEO & Director Compensation: $1.12MDr. Estuardo Aguilar-Cordova Inf. (Age 65)M.D., Ph.D., Founder & Director Compensation: $35k3 recent tradesDr. Francesca Barone M.D. (Age 46)Ph.D., Chief Scientific Officer Compensation: $506.76kMr. Charles Schoch (Age 39)Interim CFO, VP of Finance & Corporate Controller 2 recent tradesDr. Seshu Tyagarajan Ph.D. (Age 56)Chief Technical & Development Officer Compensation: $335.27kMs. Ileen B. WinickChief People OfficerMs. Susan Stewart J.D. (Age 63)L.L.M., Chief Regulatory Officer Dr. William Garrett Nichols M.D. (Age 55)M.S., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies PHAT Insider Buying ATXS Insider Buying CRMD Insider Buying CDXC Insider Buying ANNX Insider Buying MREO Insider Buying HUMA Insider Buying VERV Insider Buying CRVS Insider Buying MGTX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:CADL) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
